Zhi-Yi He Selected Research

Erythromycin (Erycette)

7/2021	Erythromycin inhibits cigarette smoke-induced inflammation through regulating the PPARγ/NF-κB signaling pathway in macrophages.
1/2020	Erythromycin reverses cigarette smoke extract-induced corticosteroid insensitivity by inhibition of the JNK/c-Jun pathway.
12/2019	Erythromycin suppresses neutrophil extracellular traps in smoking-related chronic pulmonary inflammation.
7/2015	Combination of erythromycin and dexamethasone improves corticosteroid sensitivity induced by CSE through inhibiting PI3K-δ/Akt pathway and increasing GR expression.
1/2012	Erythromycin enhances CD4+Foxp3+ regulatory T-cell responses in a rat model of smoke-induced lung inflammation.
1/2010	Effect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in chronic obstructive pulmonary disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhi-Yi He Research Topics

Disease

10	Inflammation (Inflammations) 07/2021 - 01/2010
10	Chronic Obstructive Pulmonary Disease (COPD) 05/2020 - 01/2010
4	Fibrosis (Cirrhosis) 10/2021 - 04/2015
4	Ischemic Stroke 07/2021 - 03/2018
4	Pneumonia (Pneumonitis) 12/2019 - 01/2012
4	Emphysema 12/2019 - 01/2012
4	Parkinson Disease (Parkinson's Disease) 01/2019 - 06/2015
3	Cerebral Hemorrhage 08/2022 - 01/2015
2	Stroke (Strokes) 01/2021 - 03/2019
2	Atherosclerosis 03/2019 - 03/2014
1	Hypertension (High Blood Pressure) 08/2022
1	Neoplasms (Cancer) 01/2021
1	Eosinophilia 09/2020
1	Skin Diseases (Skin Disease) 09/2020
1	Persistent Infection 09/2020
1	Opportunistic Infections (Opportunistic Infection) 09/2020
1	Infections 09/2020
1	Respiratory Tract Diseases (Respiratory Tract Disease) 05/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2019
1	Lung Abscess 10/2019
1	Idiopathic Pulmonary Fibrosis 10/2019
1	Pulmonary Plasma Cell Granuloma 10/2019
1	Cryptogenic Organizing Pneumonia 10/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Neuroinflammatory Diseases 11/2017
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 09/2016
1	Systemic Scleroderma (Systemic Sclerosis) 09/2016
1	Fatigue 01/2016
1	Cystic Fibrosis (Mucoviscidosis) 07/2015
1	Diffuse panbronchiolitis 07/2015
1	Reperfusion Injury 04/2015
1	Brain Ischemia (Cerebral Ischemia) 04/2015
1	Edema (Dropsy) 01/2015
1	Vascular Diseases (Vascular Disease) 01/2015
1	Thrombosis (Thrombus) 03/2014
1	Multiple Sclerosis 07/2011

Drug/Important Bio-Agent (IBA)

8	SmokeIBA 07/2021 - 01/2012
6	Erythromycin (Erycette)FDA LinkGeneric 07/2021 - 01/2010
5	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2020 - 07/2015
3	Bleomycin (Blenoxane)FDA LinkGeneric 09/2016 - 04/2015
2	Collagenases (Collagenase)FDA Link 08/2022 - 07/2020
2	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 08/2022 - 03/2014
2	Eosine Yellowish-(YS) (Eosin)IBA 10/2021 - 01/2021
2	Hematoxylin (Haematoxylon)IBA 10/2021 - 01/2021
2	MicroRNAs (MicroRNA)IBA 07/2021 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 05/2020 - 01/2019
2	MacrolidesIBA 06/2019 - 01/2012
2	LipopolysaccharidesIBA 11/2017 - 02/2017
2	CytokinesIBA 11/2017 - 09/2016
2	Levodopa (L Dopa)FDA LinkGeneric 01/2017 - 01/2016
2	Interleukin-17 (Interleukin 17)IBA 09/2016 - 04/2015
2	interleukin-21 (interleukin 21)IBA 04/2016 - 04/2015
2	HomocysteineIBA 06/2015 - 07/2011
1	Circular RNAIBA 01/2021
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2021
1	CarcinogensIBA 01/2021
1	AutoantibodiesIBA 09/2020
1	Immunoglobulin E (IgE)IBA 09/2020
1	Interferon-gamma (Interferon, gamma)IBA 09/2020
1	Glucose (Dextrose)FDA LinkGeneric 07/2020
1	Oxygen (Dioxygen)IBA 07/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2020
1	Histone Deacetylase 2IBA 05/2020
1	GlucocorticoidsIBA 05/2020
1	Theophylline (Theon)FDA LinkGeneric 05/2020
1	ORALIT (ORS)IBA 11/2019
1	PPAR gammaIBA 11/2019
1	SteroidsIBA 10/2019
1	GTP-Binding Proteins (G-Protein)IBA 03/2019
1	danaparoid (Orgaran)FDA Link 03/2019
1	Purinergic Receptors (Receptors, Purine)IBA 03/2019
1	Histones (Histone)IBA 01/2019
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2019
1	catalpolIBA 01/2019
1	Neuroprotective AgentsIBA 01/2019
1	Sirtuin 1IBA 01/2019
1	Thromboxane A2 (A2, Thromboxane)IBA 03/2018
1	Thromboxane-A SynthaseIBA 03/2018
1	AntigensIBA 11/2017
1	EnzymesIBA 11/2017
1	ImmunosorbentsIBA 11/2017
1	coomassie Brilliant BlueIBA 02/2017
1	Purinergic P2X7 ReceptorsIBA 02/2017
1	Phosphates (Orthophosphate)IBA 09/2016
1	Hydroxyproline (4 Hydroxyproline)IBA 09/2016
1	indium-bleomycinIBA 04/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Dopamine Agents (Dopaminergic Agents)IBA 01/2016
1	CD40 Ligand (CD40L)IBA 01/2016
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 06/2015
1	CateninsIBA 04/2015
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 04/2014
1	VitaminsIBA 07/2011
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2011
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 07/2011

Therapy/Procedure

2	Therapeutics 10/2019 - 01/2016
1	Injections 10/2021
1	Deep Brain Stimulation 01/2017